Challenge
A self-care and wellness brand preparing for European expansion required robust safety substantiation under EU Regulation (EC) No 1223/2009.Gaps in toxicological documentation and regulatory readiness posed risks to timely market entry.
Approach
SciQra delivered a focused, end-to-end safety and compliance program:
CPSRs prepared for full EU alignment
Ingredient-level toxicological risk assessments (exposure-based)
Impurity and contaminant screening across raw materials
Review of clinical data and claims substantiation
Labeling and artwork compliance validation
This structured, science-driven approach ensured that the product met the expectations of regulatory stakeholders with clarity and confidence.
Outcome
Achieved positive acceptance from EU Responsible Person (RP)
Established regulator-ready documentation framework
Positioned brand for seamless EU market entry
Accelerated overall regulatory readiness timeline
Impact
- High confidence in complex formulations
- Zero major gaps identified during RP review
- Expansion readiness across Europe
Transformation
Before: Fragmented safety documentation and uncertainty in meeting EU regulatory expectations
After: Fully aligned, RP-accepted safety dossier enabling confident European market readiness
Science-driven safety. Market-ready outcomes.